FDA Panel Reviews Diabetes Drug

By: Ashton King Email
By: Ashton King Email

An FDA panel meets Tuesday to consider pulling the diabetes drug Avandia from the market.

Dozens of studies have linked the former GlaxoSmithKline best-seller to an increased risk of heart attack.

Government scientists say studies conducted by the company are flawed and actually make the case against Avandia.

The panel will make its recommendation to the FDA after a two-day review of the drug's performance.

Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
WTVY-TV 285 N Foster Street Dothan, AL 36303 334-792-3195
Copyright © 2002-2015 - Designed by Gray Digital Media - Powered by Clickability 98300259 - wtvy.com/a?a=98300259
Gray Television, Inc.